J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
Times Cited: 184
Times Cited: 184
Times Cited
Times Co-cited
Similarity
Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
55
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
52
Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
48
Women's receptivity to testing for a genetic susceptibility to breast cancer.
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
32
Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population.
E S Tambor, B K Rimer, T S Strigo. Am J Med Genet 1997
E S Tambor, B K Rimer, T S Strigo. Am J Med Genet 1997
28
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
27
Decision-making about genetic testing among women at familial risk for breast cancer.
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
26
Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
25
Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999
22
Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.
B B Biesecker, N Ishibe, D W Hadley, T R Giambarresi, R G Kase, C Lerman, J P Struewing. Am J Med Genet 2000
B B Biesecker, N Ishibe, D W Hadley, T R Giambarresi, R G Kase, C Lerman, J P Struewing. Am J Med Genet 2000
23
Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
20
Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
19
Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations.
N A Press, Y Yasui, S Reynolds, S J Durfy, W Burke. Am J Med Genet 2001
N A Press, Y Yasui, S Reynolds, S J Durfy, W Burke. Am J Med Genet 2001
24
Interest in learning of personal genetic risk for cancer: a general population survey.
M A Andrykowski, R K Munn, J L Studts. Prev Med 1996
M A Andrykowski, R K Munn, J L Studts. Prev Med 1996
18
Factors associated with decisions about clinical BRCA1/2 testing.
K Armstrong, K Calzone, J Stopfer, G Fitzgerald, J Coyne, B Weber. Cancer Epidemiol Biomarkers Prev 2000
K Armstrong, K Calzone, J Stopfer, G Fitzgerald, J Coyne, B Weber. Cancer Epidemiol Biomarkers Prev 2000
18
Genetic testing in families with hereditary nonpolyposis colon cancer.
C Lerman, C Hughes, B J Trock, R E Myers, D Main, A Bonney, M R Abbaszadegan, A E Harty, B A Franklin, J F Lynch,[...]. JAMA 1999
C Lerman, C Hughes, B J Trock, R E Myers, D Main, A Bonney, M R Abbaszadegan, A E Harty, B A Franklin, J F Lynch,[...]. JAMA 1999
16
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
E J Meijers-Heijboer, L C Verhoog, C T Brekelmans, C Seynaeve, M M Tilanus-Linthorst, A Wagner, L Dukel, P Devilee, A M van den Ouweland, A N van Geel,[...]. Lancet 2000
E J Meijers-Heijboer, L C Verhoog, C T Brekelmans, C Seynaeve, M M Tilanus-Linthorst, A Wagner, L Dukel, P Devilee, A M van den Ouweland, A N van Geel,[...]. Lancet 2000
16
Attitudes towards cancer predictive testing and transmission of information to the family.
C Julian-Reynier, F Eisinger, P Vennin, F Chabal, Y Aurran, C Noguès, Y J Bignon, M Machelard-Roumagnac, C Maugard-Louboutin, D Serin,[...]. J Med Genet 1996
C Julian-Reynier, F Eisinger, P Vennin, F Chabal, Y Aurran, C Noguès, Y J Bignon, M Machelard-Roumagnac, C Maugard-Louboutin, D Serin,[...]. J Med Genet 1996
15
Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
15
Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer.
I M Lipkus, D Iden, J Terrenoire, J R Feaganes. Cancer Epidemiol Biomarkers Prev 1999
I M Lipkus, D Iden, J Terrenoire, J R Feaganes. Cancer Epidemiol Biomarkers Prev 1999
15
Effects of individualized breast cancer risk counseling: a randomized trial.
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
14
Psychological responses to BRCA1 mutation testing: preliminary findings.
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
14
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
13
Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates.
R T Croyle, C Lerman. Prev Med 1993
R T Croyle, C Lerman. Prev Med 1993
13
What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.
C Lerman, C Hughes, S J Lemon, D Main, C Snyder, C Durham, S Narod, H T Lynch. J Clin Oncol 1998
C Lerman, C Hughes, S J Lemon, D Main, C Snyder, C Durham, S Narod, H T Lynch. J Clin Oncol 1998
13
The influence of psychological distress on use of genetic testing for cancer risk.
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
13
Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
Joan L Bottorff, Pamela A Ratner, Lynda G Balneaves, Chris G Richardson, Mary McCullum, Tom Hack, Karen Chalmers, Jane Buxton. Cancer Epidemiol Biomarkers Prev 2002
Joan L Bottorff, Pamela A Ratner, Lynda G Balneaves, Chris G Richardson, Mary McCullum, Tom Hack, Karen Chalmers, Jane Buxton. Cancer Epidemiol Biomarkers Prev 2002
20
Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network.
C Julian-Reynier, H Sobol, C Sévilla, C Noguès, P Bourret. Psychooncology 2000
C Julian-Reynier, H Sobol, C Sévilla, C Noguès, P Bourret. Psychooncology 2000
31
Awareness and attitudes concerning BRCA gene testing.
A Mogilner, M Otten, J D Cunningham, S T Brower. Ann Surg Oncol 1998
A Mogilner, M Otten, J D Cunningham, S T Brower. Ann Surg Oncol 1998
25
Attitudes toward genetic testing for colon cancer risk.
K R Smith, R T Croyle. Am J Public Health 1995
K R Smith, R T Croyle. Am J Public Health 1995
20
Hereditary cancer risk notification and testing: how interested is the general population?
M A Andrykowski, R Lightner, J L Studts, R K Munn. J Clin Oncol 1997
M A Andrykowski, R Lightner, J L Studts, R K Munn. J Clin Oncol 1997
20
Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
12
Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.
M Dorval, A F Patenaude, K A Schneider, S A Kieffer, L DiGianni, K J Kalkbrenner, J I Bromberg, L A Basili, K Calzone, J Stopfer,[...]. J Clin Oncol 2000
M Dorval, A F Patenaude, K A Schneider, S A Kieffer, L DiGianni, K J Kalkbrenner, J I Bromberg, L A Basili, K Calzone, J Stopfer,[...]. J Clin Oncol 2000
12
Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population.
Emily A Peterson, Kara J Milliron, Karen E Lewis, Susan D Goold, Sofia D Merajver. Cancer Epidemiol Biomarkers Prev 2002
Emily A Peterson, Kara J Milliron, Karen E Lewis, Susan D Goold, Sofia D Merajver. Cancer Epidemiol Biomarkers Prev 2002
13
Psychological distress and surveillance behaviors of women with a family history of breast cancer.
K M Kash, J C Holland, M S Halper, D G Miller. J Natl Cancer Inst 1992
K M Kash, J C Holland, M S Halper, D G Miller. J Natl Cancer Inst 1992
11
A descriptive study of BRCA1 testing and reactions to disclosure of test results.
H T Lynch, S J Lemon, C Durham, S T Tinley, C Connolly, J F Lynch, J Surdam, E Orinion, S Slominski-Caster, P Watson,[...]. Cancer 1997
H T Lynch, S J Lemon, C Durham, S T Tinley, C Connolly, J F Lynch, J Surdam, E Orinion, S Slominski-Caster, P Watson,[...]. Cancer 1997
11
Attitudes toward colon cancer gene testing: factors predicting test uptake.
A M Codori, G M Petersen, D L Miglioretti, E K Larkin, M T Bushey, C Young, J D Brensinger, K Johnson, J A Bacon, S V Booker. Cancer Epidemiol Biomarkers Prev 1999
A M Codori, G M Petersen, D L Miglioretti, E K Larkin, M T Bushey, C Young, J D Brensinger, K Johnson, J A Bacon, S V Booker. Cancer Epidemiol Biomarkers Prev 1999
11
Psychosocial aspects of cancer genetics: women at high risk for breast and ovarian cancer.
K M Kash, K Ortega-Verdejo, M K Dabney, J C Holland, D G Miller, M P Osborne. Semin Surg Oncol 2000
K M Kash, K Ortega-Verdejo, M K Dabney, J C Holland, D G Miller, M P Osborne. Semin Surg Oncol 2000
33
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
11
Intention to pursue genetic testing for breast cancer among women due for screening mammography.
Karin Gwyn, Sally W Vernon, Patrick M Conoley. Cancer Epidemiol Biomarkers Prev 2003
Karin Gwyn, Sally W Vernon, Patrick M Conoley. Cancer Epidemiol Biomarkers Prev 2003
30
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D F Easton, D Ford, D T Bishop. Am J Hum Genet 1995
D F Easton, D Ford, D T Bishop. Am J Hum Genet 1995
10
Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers.
C Lerman, J Marshall, J Audrain, A Gomez-Caminero. Int J Cancer 1996
C Lerman, J Marshall, J Audrain, A Gomez-Caminero. Int J Cancer 1996
11
Uptake of presymptomatic predictive testing for Huntington's disease.
D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
10
A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style.
C Lerman, M D Schwartz, S M Miller, M Daly, C Sands, B K Rimer. Health Psychol 1996
C Lerman, M D Schwartz, S M Miller, M Daly, C Sands, B K Rimer. Health Psychol 1996
9
Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups.
K Glanz, J Grove, C Lerman, C Gotay, L Le Marchand. Cancer Epidemiol Biomarkers Prev 1999
K Glanz, J Grove, C Lerman, C Gotay, L Le Marchand. Cancer Epidemiol Biomarkers Prev 1999
10
Attitudes to genetic testing for breast cancer susceptibility in women at increased risk developing hereditary breast cancer.
B Meiser, P Butow, A Barratt, G Suthers, M Smith, A Colley, E Thompson, K Tucker. J Med Genet 2000
B Meiser, P Butow, A Barratt, G Suthers, M Smith, A Colley, E Thompson, K Tucker. J Med Genet 2000
19
Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.
. J Clin Oncol 1996
. J Clin Oncol 1996
9
Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.
C Lerman, C Hughes, R T Croyle, D Main, C Durham, C Snyder, A Bonney, J F Lynch, S A Narod, H T Lynch. Prev Med 2000
C Lerman, C Hughes, R T Croyle, D Main, C Durham, C Snyder, A Bonney, J F Lynch, S A Narod, H T Lynch. Prev Med 2000
9
Interest in BRCA1/2 testing in a primary care population.
Katrina Armstrong, Barbara Weber, Peter A Ubel, Carmen Guerra, J Sanford Schwartz. Prev Med 2002
Katrina Armstrong, Barbara Weber, Peter A Ubel, Carmen Guerra, J Sanford Schwartz. Prev Med 2002
16
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
L C Hartmann, T A Sellers, D J Schaid, T S Frank, C L Soderberg, D L Sitta, M H Frost, C S Grant, J H Donohue, J E Woods,[...]. J Natl Cancer Inst 2001
L C Hartmann, T A Sellers, D J Schaid, T S Frank, C L Soderberg, D L Sitta, M H Frost, C S Grant, J H Donohue, J E Woods,[...]. J Natl Cancer Inst 2001
9
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.